Halozyme CFO receives new stock option and RSU grants
HALOZYME THERAPEUTICS, INC. reported that SVP and Chief Financial Officer Darren Snellgrove received new equity awards on July 1, 2026.
Rhea-AI Filing Summary
HALOZYME THERAPEUTICS, INC. reported that SVP and Chief Financial Officer Darren Snellgrove received new equity awards on July 1, 2026. He was granted options to purchase 127,432 shares of common stock at an exercise price of $77.01 per share, along with 41,554 restricted stock units (RSUs).
The options begin vesting one-fourth on the first vesting date and then in equal monthly installments over 48 months, while the RSUs vest in three equal annual installments starting on the first anniversary of the grant date. These are compensation-related grants, not open‑market purchases or sales, and increase the CFO’s potential future ownership if vesting and exercise conditions are met.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 168,986 shares
Grant/Award
2 txns
Insider
Snellgrove Darren
Role
SVP, Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 41,554 | $0.00 | $0.00 |
| Grant/Award | Option to Purchase Common Stock | 127,432 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 41,554 contracts (Direct);
Option to Purchase Common Stock — 127,432 contracts (Direct)
Footnotes (2)
- F1. This award vests one-third on the first anniversary of the grant date and then one-third on each anniversary date thereafter.
- F2. This option vests one-fourth on such date and then 1/48th monthly thereafter.
Key Figures
Stock options granted: 127,432 shares
Option exercise price: $77.01 per share
RSUs granted: 41,554 units
+3 more
6 metrics
Stock options granted
127,432 shares
Option to Purchase Common Stock granted to CFO on July 1, 2026
Option exercise price
$77.01 per share
Exercise price for 127,432 stock options granted to CFO
RSUs granted
41,554 units
Restricted Stock Units granted to CFO on July 1, 2026
Options expiration
July 1, 2036
Expiration date of CFO stock option grant
Option vesting structure
1/4 then 1/48 monthly
Options vest one-fourth initially, then monthly over remaining term
RSU vesting structure
1/3 annually over 3 years
RSUs vest in three equal annual installments from grant date anniversary
Key Terms
Option to Purchase Common Stock, Restricted Stock Units, exercise price, grant date, +1 more
5 terms
Option to Purchase Common Stock financial
"security_title: Option to Purchase Common Stock"
Restricted Stock Units financial
"security_title: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"conversion_or_exercise_price: 77.0100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
grant date financial
"This award vests one-third on the first anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vests financial
"This option vests one-fourth on such date and then 1/48th monthly thereafter."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did HALO (Halozyme) CFO Darren Snellgrove receive?
Darren Snellgrove received stock options for 127,432 shares and 41,554 restricted stock units. Both awards are tied to Halozyme common stock and represent compensation-based grants rather than open-market transactions, potentially increasing his future ownership if vesting and exercise conditions are satisfied.
What is the exercise price of the new Halozyme CFO stock options?
The new options granted to Halozyme CFO Darren Snellgrove have an exercise price of $77.01 per share. This means he can buy Halozyme common stock at $77.01 once the options vest, provided he remains eligible and exercises before the option expiration date in 2036.
How many RSUs were granted to the Halozyme CFO in this Form 4?
The Halozyme CFO was granted 41,554 restricted stock units. Each RSU represents a right to receive one share of Halozyme common stock, subject to vesting over time and continued service, rather than an immediate share issuance or cash transaction on the grant date.
How do the Halozyme CFO stock options vest under this grant?
The options granted to the Halozyme CFO vest one-fourth on the initial vesting date, then 1/48th monthly thereafter. This creates a four-year vesting schedule, encouraging longer-term employment and alignment with shareholder interests as more of the award becomes exercisable over time.
What is the vesting schedule for the Halozyme CFO restricted stock units?
The restricted stock units vest one-third on the first anniversary of the grant date and one-third on each of the next two anniversaries. This three-year, time-based schedule ties the CFO’s compensation to continued service and long-term company performance rather than short-term stock movements.
When do the new Halozyme CFO stock options expire?
The options granted to the Halozyme CFO expire on July 1, 2036. He can exercise vested options any time between vesting and this expiration date, subject to company policies and trading rules, after which any unexercised options will cease to be exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
